Free medication will soon be provided to low-income cancer patients in the UAE.
It comes following a new agreement between the Ministry of Health and Prevention (MoHAP) and pharmaceutical company, AstraZeneca.
The initiative will benefit those battling bladder and lung cancer as well as patients with lymphoma and acute asthma.
Commenting on the agreement, Leon Wang, Executive VP at International AstraZeneca said: "This initiative, which includes new and innovative treatment for some types of cancer and respiratory diseases, would help patients, who are under limited medical insurance."
Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department said that the initiative would help enhance community responsibility values for companies.
Over 800 arrested in UAE-led operation to fight environmental crime in Amazon basin
Dubai expands road capacity on key traffic corridor
Dubai Police correctional establishments recognised for human rights excellence
Two face legal action over offensive social media broadcast
UAE, Bahrain foreign ministers discuss regional developments
UAE sets up health camp for children with congenital heart disease in Zanzibar
UAE expresses solidarity with Greece, Denmark after helicopter crash
UAE, Qatar discuss regional developments and security
